RGT anti-a b bcln 10ML BTL orth BB

Ended Awarded

Contract number
SPE2D326F311E
Awardee
Awarding agency
Obligated
$4,909

Award facts

Contract value 100% obligated
$4,909.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

Medical Supply Chain (Defense) issued a $4,909.20 firm fixed-price delivery order to Quidelortho Sales Company, LLC on July 27, 2026, for a blood bank reagent identified as RGT ANTI-A B BCLN 10ML BTL ORTH BB (line item 4572510853). The order was issued without set-aside. Quidelortho is a HUBZone-certified joint venture and child entity of Ortho-Clinical Diagnostics, Inc. Place of performance is Raritan, NJ 08869, and the order's ultimate completion date is July 28, 2026. The $4,909.20 figure is the order's stated ceiling value.

Quick answers

Who was awarded contract SPE2D326F311E?

SPE2D326F311E was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on July 27, 2026.

How much is contract SPE2D326F311E worth?

The government has obligated $4,909 on SPE2D326F311E.

Is contract SPE2D326F311E an order under another contract?

Yes. SPE2D326F311E is a delivery order under SPE2D018D0005, an indefinite delivery contract.

Was contract SPE2D326F311E competed?

The extent of competition for SPE2D326F311E was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award